First Tracks Biotherapeutics, Inc.
SEC CIK 2091349 · TRAX · last insider filing 2026-06-17
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Fenton Dennis M | Director | filed 2026 - 2026 |
| Orwin John A | Director | filed 2026 - 2026 |
| Schmid John P. | Director | filed 2026 - 2026 |
| Marquet Magda | Director | filed 2026 - 2026 |
| Jain Rita | Director | filed 2026 - 2026 |
| Ware J. Anthony | Director | filed 2026 - 2026 |
| Faga Daniel | Director · President, CEO | filed 2026 - 2026 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Lizzul Paul F. | Chief Medical Officer | filed 2026 - 2026 |
| Tamboli Ajim | Chief Financial Officer | filed 2026 - 2026 |
| Stone Benjamin | Chief Business Officer | filed 2026 - 2026 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.